URGENT: Sell these stocks by October 13th

The $1.3 Trillion Global Pharma Industry's #1 New Disruptor? Pharma supply chain companies are absolutely killing it. This one, in particular, recently joined the Nasdaq. With 160+ clients and vendors, they have a global network that is mind-blowing. Killer revenue growth of 40% gross profit growth of nearly 120% paints a picture of a Pharma company on the rise.  [AD] Strong subsidiaries and an industry-leading management team, could see them thrive... Former Wall Street insider reveals his biggest call yet J.R. Butts has worked on Wall Street for nearly a decade… and in recent years, his calls have returned HUGE gains of 158%… 165%… and 299%. But incredibly, he says his next call could return 886%—more than each of these combined!   To see how you could more than 9x your money from his latest discovery… click here now! * Don't trust the banks with your hard earned money. Ensure financial stability with the Stock Market Correction Plan. [AD] * URGENT: Sell these stocks by October 13th [AD] * IPO Report: ‘SPAC King’ Is Throwing In The Towel On Two Vehicles After Failing To Find Target Companies In Time

Stockguru LLC 711 SW 24th Ave Boynton, Beach, FL 33435 This email is being sent from Investing Chatter. If you no longer wish to receive Investing Chatter emails, please click to unsubscribe.

DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.